Stacie B Dusetzina

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. pmc Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics
    Stacie B Dusetzina
    Division of General Medicine and Clinical Epidemiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
    PLoS ONE 8:e63973. 2013
  2. pmc Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010
    Stacie B Dusetzina
    Division of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill, 5034 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Breast Cancer Res Treat 137:285-96. 2013
  3. doi request reprint Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D
    Bradley N Gaynes
    Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Clin Psychopharmacol 32:114-9. 2012
  4. doi request reprint Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an a
    Aaron J Katz
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Pharmacotherapy 32:234-43. 2012
  5. pmc Confounding control in a nonexperimental study of STAR*D data: logistic regression balanced covariates better than boosted CART
    Alan R Ellis
    Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7590, USA
    Ann Epidemiol 23:204-9. 2013
  6. pmc Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data
    Alan R Ellis
    Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, NC 27599, USA
    Pharmacoepidemiol Drug Saf 22:138-44. 2013
  7. pmc Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
    Bradley N Gaynes
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7160, USA
    Depress Anxiety 28:989-98. 2011
  8. doi request reprint Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
    J Am Pharm Assoc (2003) 49:760-8. 2009
  9. pmc Prescription refill records as a screening tool to identify antidepressant non-adherence
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Pharmacoepidemiol Drug Saf 19:33-7. 2010
  10. doi request reprint Medicaid prescription drug utilization and expenditures following Part D
    Joel F Farley
    University of North Carolina at Chapel Hill, UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, Chapel Hill, NC 27599, USA
    J Health Care Poor Underserved 21:715-28. 2010

Detail Information

Publications10

  1. pmc Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics
    Stacie B Dusetzina
    Division of General Medicine and Clinical Epidemiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
    PLoS ONE 8:e63973. 2013
    ..If channeling is not identified and appropriately managed it might lead to confounding in observational comparative effectiveness studies...
  2. pmc Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010
    Stacie B Dusetzina
    Division of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill, 5034 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Breast Cancer Res Treat 137:285-96. 2013
    ..Whether patients and providers will continue to avoid strong inhibitor antidepressants is yet to be seen, but clinicians appear to be responsive to drug interaction risk information in this setting...
  3. doi request reprint Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D
    Bradley N Gaynes
    Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Clin Psychopharmacol 32:114-9. 2012
    ....
  4. doi request reprint Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an a
    Aaron J Katz
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Pharmacotherapy 32:234-43. 2012
    ..To determine whether distressing adverse events (DAEs) experienced during initial antidepressant treatment are associated with subsequent DAEs after switching to a second antidepressant...
  5. pmc Confounding control in a nonexperimental study of STAR*D data: logistic regression balanced covariates better than boosted CART
    Alan R Ellis
    Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7590, USA
    Ann Epidemiol 23:204-9. 2013
    ..Propensity scores (PSs), a powerful bias-reduction tool, can balance treatment groups on measured covariates in nonexperimental studies. We demonstrate the use of multiple PS estimation methods to optimize covariate balance...
  6. pmc Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data
    Alan R Ellis
    Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, NC 27599, USA
    Pharmacoepidemiol Drug Saf 22:138-44. 2013
    ..Using effectiveness data, we describe lessons learned from sensitivity analyses with matched and weighted estimates...
  7. pmc Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
    Bradley N Gaynes
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7160, USA
    Depress Anxiety 28:989-98. 2011
    ..We explored whether clinical outcomes differ by treatment strategy following initial antidepressant treatment failure among patients with and without clinically relevant symptom clusters...
  8. doi request reprint Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
    J Am Pharm Assoc (2003) 49:760-8. 2009
    ....
  9. pmc Prescription refill records as a screening tool to identify antidepressant non-adherence
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Pharmacoepidemiol Drug Saf 19:33-7. 2010
    ..Accordingly, our purpose was to determine the shortest gap in medication supply that is predictive of discontinuation, while minimizing false positive results...
  10. doi request reprint Medicaid prescription drug utilization and expenditures following Part D
    Joel F Farley
    University of North Carolina at Chapel Hill, UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, Chapel Hill, NC 27599, USA
    J Health Care Poor Underserved 21:715-28. 2010
    ..Our results provide a glimpse of the impact of Part D on long-term growth in the Medicaid prescription drug benefit...